GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Other Current Liabilities

Noile-Immune Biotech (TSE:4893) Other Current Liabilities : 円43.9 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Other Current Liabilities?

Noile-Immune Biotech's other current liabilities for the quarter that ended in Mar. 2024 was 円43.9 Mil.

Noile-Immune Biotech's quarterly other current liabilities declined from Sep. 2023 (円62.1 Mil) to Dec. 2023 (円37.3 Mil) but then increased from Dec. 2023 (円37.3 Mil) to Mar. 2024 (円43.9 Mil).

Noile-Immune Biotech's annual other current liabilities increased from Dec. 2021 (円27.9 Mil) to Dec. 2022 (円99.1 Mil) but then declined from Dec. 2022 (円99.1 Mil) to Dec. 2023 (円37.3 Mil).


Noile-Immune Biotech Other Current Liabilities Historical Data

The historical data trend for Noile-Immune Biotech's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Other Current Liabilities Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
- - - -

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only - - - - -

Noile-Immune Biotech Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Noile-Immune Biotech Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Noile-Immune Biotech (TSE:4893) Business Description

Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines